Citation: Rj. Macfadyen et Sd. Pringle, ABNORMAL HEART-RATE-VARIABILITY AND OR LATE POTENTIALS IN HYPERTENSIVE LEFT-VENTRICULAR HYPERTROPHY - ARE THEY CHICKENS, EGGS OR AN OMELETTE/, Journal of human hypertension, 12(1), 1998, pp. 3-5
Authors:
BONNAR CE
MACFADYEN RJ
PRINGLE SD
STRUTHERS AD
Citation: Ce. Bonnar et al., QT-DISPERSION IS RELATED TO SYMPATHETIC TONE AFTER ACUTE MYOCARDIAL-INFARCTION AND IN CHRONIC HEART-FAILURE, Journal of the American College of Cardiology, 31(2), 1998, pp. 132-132
Authors:
SHIELS P
MACFADYEN RJ
LIM PO
MACDONALD TM
Citation: P. Shiels et al., ECHOCARDIOGRAPHIC EVALUATION OF VENTRICULAR DIASTOLIC FUNCTION - IMPLICATIONS FOR TREATMENT, HEART, 77(3), 1997, pp. 294-294
Authors:
BONNAR CE
GILLESPIE ND
MACFADYEN RJ
OGSTON SS
STRUTHERS AD
Citation: Ce. Bonnar et al., QT-DISPERSION IS SIGNIFICANTLY INCREASED BETWEEN 6 AM AND 8 AM IN HEART-FAILURE PATIENTS - A POSSIBLE ROLE IN SUDDEN-DEATH, Journal of the American College of Cardiology, 29(2), 1997, pp. 88151-88151
Authors:
MACFADYEN RJ
BARR CS
STURROCK NDC
FENWICK M
STRUTHERS AD
Citation: Rj. Macfadyen et al., FURTHER EVIDENCE THAT CHRONIC PERINDOPRIL TREATMENT MAINTAINS NEUROHORMONAL SUPPRESSION BUT DOES NOT LOWER BLOOD-PRESSURE IN CHRONIC CARDIAC-FAILURE, British journal of clinical pharmacology, 44(1), 1997, pp. 69-75
Citation: Rj. Macfadyen et Ad. Struthers, THE PRACTICAL ASSESSMENT OF COMPLIANCE WITH ACE-INHIBITOR THERAPY - ANOVEL-APPROACH, Journal of cardiovascular pharmacology, 29(1), 1997, pp. 119-124
Authors:
MACFADYEN RJ
LEE AF
ROBSON J
COUTIE WJ
MCFARLANE L
MORTON JJ
PRINGLE SD
STRUTHERS AD
Citation: Rj. Macfadyen et al., HOW COMMON IS ANGIOTENSIN-II AND ALDOSTERONE REACTIVATION IN HEART-FAILURE PATIENTS ON ACE-INHIBITORS, Circulation, 96(8), 1997, pp. 109-109
Authors:
MACFADYEN RJ
MCLEOD CJ
SHIELS P
SMITH WR
MACDONALD TM
Citation: Rj. Macfadyen et al., COMMUNITY DIAGNOSED BREATHLESSNESS AND SYMPTOMATIC ISOLATED DIASTOLICDYSFUNCTION (THE ARBROATH STUDY), Circulation, 96(8), 1997, pp. 3592-3592
Citation: Ib. Squire et al., DIFFERING EARLY BLOOD-PRESSURE AND RENIN-ANGIOTENSIN SYSTEM RESPONSESTO THE FIRST DOSE OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN CONGESTIVE-HEART-FAILURE (VOL 27, PG 657, 1996), Journal of cardiovascular pharmacology, 28(3), 1996, pp. 479-479
Authors:
MCINTYRE M
MACFADYEN RJ
MEREDITH PA
BROUARD R
REID JL
Citation: M. Mcintyre et al., DOSE-RANGING STUDY OF THE ANGIOTENSIN-II RECEPTOR ANTAGONIST IRBESARTAN (SR47436 BMS-186295) ON BLOOD-PRESSURE AND NEUROHORMONAL EFFECTS INSALT-DEPLETE MEN/, Journal of cardiovascular pharmacology, 28(1), 1996, pp. 101-106
Citation: Ib. Squire et al., DIFFERING EARLY BLOOD-PRESSURE AND RENIN-ANGIOTENSIN SYSTEM RESPONSESTO THE FIRST DOSE OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN CONGESTIVE-HEART-FAILURE, Journal of cardiovascular pharmacology, 27(5), 1996, pp. 657-666
Citation: Pbm. Clarkson et al., EFFECTS OF BRAIN NATRIURETIC PEPTIDE ON EXERCISE HEMODYNAMICS AND NEUROHORMONES IN ISOLATED DIASTOLIC HEART-FAILURE, Circulation, 93(11), 1996, pp. 2037-2042
Authors:
MACFADYEN RJ
MACDONALD T
CLARKSON P
WHEELDON NM
Citation: Rj. Macfadyen et al., OPEN ACCESS ECHOCARDIOGRAPHY - SINGLE ASSESSMENT MAY BE DANGEROUS, BMJ. British medical journal, 311(7000), 1995, pp. 327-327
Authors:
PRASAD N
MACFADYEN RJ
OGSTON SA
MACDONALD TM
Citation: N. Prasad et al., ELEVATED BLOOD-PRESSURE DURING THE FIRST 2 HOURS OF AMBULATORY BLOOD-PRESSURE MONITORING - A STUDY COMPARING CONSECUTIVE 24-HOUR MONITORINGPERIODS, Journal of hypertension, 13(3), 1995, pp. 291-295
Authors:
MCINTYRE M
MACFADYEN RJ
MEREDITH PA
MENARD J
BRUNNER HR
INSUASTY J
REID JL
Citation: M. Mcintyre et al., COMPARISON OF THE ORAL ANGIOTENSIN-II RECEPTOR ANTAGONIST UP-269-6 ORENALAPRIL 20 MG ON BLOOD-PRESSURE AND NEUROHORMONAL EFFECTS IN SALT-DEPLETE MAN, Journal of cardiovascular pharmacology, 25(6), 1995, pp. 994-1000
Citation: Jk. Doig et al., HEMODYNAMIC AND RENAL RESPONSES TO ORAL LOSARTAN POTASSIUM DURING SALT DEPLETION OR SALT REPLETION IN NORMAL HUMAN VOLUNTEERS, Journal of cardiovascular pharmacology, 25(4), 1995, pp. 511-517
Authors:
MACFADYEN RJ
JONES CR
DOIG JK
BIRNBOCK H
REID JL
Citation: Rj. Macfadyen et al., RESPONSES TO AN ORALLY-ACTIVE RENIN INHIBITOR, REMIKIREN (RO-42-5892), AFTER CONTROLLED SALT DEPLETION IN HUMANS, Journal of cardiovascular pharmacology, 25(3), 1995, pp. 347-353
Citation: Rj. Macfadyen et N. Prasad, CLINICAL-PHARMACOLOGY AND CLASSIFICATION OF ANTIARRHYTHMIC DRUGS, British Journal of Hospital Medicine, 54(10), 1995, pp. 515-519